Oslo - Delayed Quote NOK

Photocure ASA (PHO.OL)

55.40 +1.00 (+1.84%)
At close: April 26 at 4:25 PM GMT+2
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for PHO.OL

Recent News: PHO.OL

View More
European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care

European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care
PR Newswire 20 days ago
Photocure to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Photocure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
PR Newswire 23 days ago
New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy

New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy
PR Newswire last month
Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting

Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting
PR Newswire last month
Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN

Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN
PR Newswire 2 months ago
Photocure ASA: Results for the fourth quarter of 2023

Photocure ASA: Results for the fourth quarter of 2023
PR Newswire 2 months ago

Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China
PR Newswire 4 months ago

Photocure to present at four investor conferences in November/December 2023
PR Newswire 5 months ago
Photocure ASA: Results for the third quarter of 2023

Photocure ASA: Results for the third quarter of 2023
PR Newswire 5 months ago

Positive Results for Hexvix Phase III Clinical Trial in China Presented at the SIU 2023 Congress
PR Newswire 6 months ago

New Health Economic analysis in France concludes there is insignificant cost difference between White Light and Blue Light Cystoscopy use when applying ccAFU guidelines
PR Newswire 6 months ago
Photocure ASA: Change of Board Composition

Photocure ASA: Change of Board Composition
PR Newswire 6 months ago
View More

Related Tickers

NEWBRY.ST Newbury Pharmaceuticals AB (publ)
3.4100
+2.71%
 
0512.HK Grand Pharmaceutical Group Limited
4.320
+1.41%
 
HLUN-A.CO H. Lundbeck A/S
28.15
+0.72%
 
NXS.AX Next Science Limited
0.3400
+7.94%
 
BIOG-B.ST BioGaia AB (publ)
115.20
+1.23%
 
HLUN-B.CO H. Lundbeck A/S
32.92
+1.11%
 
HROW Harrow, Inc.
10.53
+5.30%
 
CPH.TO Cipher Pharmaceuticals Inc.
8.50
0.00%
 
SIGA SIGA Technologies, Inc.
8.79
+1.74%
 
TEVA Teva Pharmaceutical Industries Limited
13.81
+4.23%